JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BLE
5351
DELISTED
BlackRock Municipal Income Trust II
BLE
| $138K | ﹤0.01% |
12,908
+11,589
| +879% | +$114K |
2023 Q3
1 quarter
|
|
5352
Teucrium Corn Fund
CORN
$137M
| $137K | ﹤0.01% |
6,357
-306
| -5% | -$6.79K |
2016 Q2
30 quarters
|
|
5353
Nuveen Global High Income Fund
JGH
$326M
| $137K | ﹤0.01% |
11,238
+1,559
| +16% | +$17.5K |
2023 Q3
1 quarter
|
|
5354
Western New England Bancorp
WNEB
$278M
| $137K | ﹤0.01% |
15,210
+12,212
| +407% | +$93.2K |
2017 Q4
24 quarters
|
|
5355
Acme United Corp
ACU
$243M
| $136K | ﹤0.01% |
+3,183
| New | +$111K |
2023 Q4
0 quarters
|
|
5356
ORIX
IX
$38.5B
| $136K | ﹤0.01% |
7,255
-7,205
| -50% | -$131K |
2013 Q2
42 quarters
|
|
5357
Omeros
OMER
$1.33B
| $135K | ﹤0.01% |
41,315
-11,763
| -22% | -$24.9K |
2017 Q4
24 quarters
|
|
|
FUSN
5358
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $135K | ﹤0.01% |
14,033
+14,031
| +701,550% | +$68.2K |
2020 Q4
12 quarters
|
|
|
CALB
5359
DELISTED
California BanCorp Common Stock
CALB
| $134K | ﹤0.01% |
5,427
+4,146
| +324% | +$92K |
2023 Q3
1 quarter
|
|
5360
Annexon
ANNX
$791M
| $134K | ﹤0.01% |
29,585
-10,034
| -25% | -$24.8K |
2020 Q3
13 quarters
|
|
5361
PUT
Viking Therapeutics
VKTX
$3.77B
| $134K | ﹤0.01% |
7,200
| – | – |
2023 Q2
2 quarters
|
|
5362
Simplify Volatility Premium ETF
SVOL
$514M
| $133K | ﹤0.01% |
5,843
-11,099
| -66% | -$250K |
2023 Q3
1 quarter
|
|
5363
John Hancock Multifactor Developed International ETF
JHMD
$955M
| $133K | ﹤0.01% |
4,068
+306
| +8% | +$9.36K |
2023 Q3
1 quarter
|
|
5364
Nokia
NOK
$59.3B
| $132K | ﹤0.01% |
38,725
-1,941,823
| -98% | -$6.59M |
2013 Q2
42 quarters
|
|
5365
Outdoor Holding Co
POWW
$267M
| $132K | ﹤0.01% |
62,897
+679
| +1% | +$1.55K |
2021 Q2
10 quarters
|
|
|
IVAC
5366
DELISTED
Intevac Inc
IVAC
| $131K | ﹤0.01% |
30,401
+5,801
| +24% | +$21.6K |
2023 Q1
3 quarters
|
|
5367
Century Casinos
CNTY
$30.4M
| $131K | ﹤0.01% |
26,863
+9,033
| +51% | +$41.7K |
2017 Q4
24 quarters
|
|
5368
BlackRock Limited Duration Income Trust
BLW
$458M
| $131K | ﹤0.01% |
+9,361
| New | +$122K |
2023 Q4
0 quarters
|
|
5369
WPP
WPP
$5.32B
| $131K | ﹤0.01% |
2,749
+92
| +3% | +$4.12K |
2013 Q2
42 quarters
|
|
5370
Evolution Petroleum
EPM
$144M
| $131K | ﹤0.01% |
22,495
+1,896
| +9% | +$11.6K |
2017 Q3
25 quarters
|
|
|
IMGN
5371
PUT
DELISTED
Immunogen Inc
IMGN
| $130K | ﹤0.01% |
4,400
| – | – |
2023 Q3
1 quarter
|
|
5372
Acumen Pharmaceuticals
ABOS
$147M
| $130K | ﹤0.01% |
33,945
+22,920
| +208% | +$68K |
2021 Q3
9 quarters
|
|
|
ALLK
5373
DELISTED
Allakos
ALLK
| $130K | ﹤0.01% |
47,742
-12,260
| -20% | -$27.6K |
2018 Q3
21 quarters
|
|
5374
InfuSystem Holdings
INFU
$260M
| $130K | ﹤0.01% |
12,354
| – | – |
2020 Q2
14 quarters
|
|
|
GRTS
5375
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $129K | ﹤0.01% |
63,174
-11,241
| -15% | -$20.5K |
2018 Q3
21 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.